Results of a phase IIb study in recurrent or refractory glioblastoma patients with the TGF-beta-2 inhibitor AP 12009

Hau, P. and Bogdahn, U. and Olyushin, V. E. and Mahapatra, A. and Parfenov, V. E. and Venkataramana, K. and Ludwig, S. and Jachimczak, P. and Heinrichs, H. and Schlingensiepen, K. (2007) Results of a phase IIb study in recurrent or refractory glioblastoma patients with the TGF-beta-2 inhibitor AP 12009. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 12521. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Depositing User: Petra Gürster
Date Deposited: 30 Oct 2020 08:57
Last Modified: 30 Oct 2020 08:57
URI: https://pred.uni-regensburg.de/id/eprint/32603

Actions (login required)

View Item View Item